V, A., L, P., A, T., O, K., F, F., R, B., . . . F, S. (2020). Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide. British journal of haematology, 189(4), e133. https://doi.org/10.1111/bjh.16558
Chicago Style (17th ed.) CitationV, Adema, et al. "Distinct Mutational Pattern of Myelodysplastic Syndromes with and Without 5q- Treated with Lenalidomide." British Journal of Haematology 189, no. 4 (2020): e133. https://doi.org/10.1111/bjh.16558.
MLA (9th ed.) CitationV, Adema, et al. "Distinct Mutational Pattern of Myelodysplastic Syndromes with and Without 5q- Treated with Lenalidomide." British Journal of Haematology, vol. 189, no. 4, 2020, p. e133, https://doi.org/10.1111/bjh.16558.
Warning: These citations may not always be 100% accurate.